PMID- 29481926 OWN - NLM STAT- MEDLINE DCOM- 20181023 LR - 20181023 IS - 1615-5947 (Electronic) IS - 0890-5096 (Linking) VI - 50 DP - 2018 Jul TI - Anticoagulation Obtained below the Arterial Clamp Using a Single Fixed Bolus of Heparin in Vascular Surgery: A Pilot Study. PG - 242-248 LID - S0890-5096(18)30162-6 [pii] LID - 10.1016/j.avsg.2017.11.060 [doi] AB - BACKGROUND: No clear recommendations exist regarding the optimal dosing of unfractionated heparin (UFH) during vascular surgery. Moreover, little is known about the effect of the UFH bolus downstream of the arterial clamp, where stasis and inflammation can possibly alter the anticoagulation obtained. METHODS: The aim of our prospective observational study was to assess anticoagulation below the arterial clamp and its clinical impact on the quality of revascularization. Thirty-six patients American Society of Anaesthesiologists physical status (ASA) grade I-III undergoing open revascularization surgeries were included. A baseline activated coagulation time (ACT) was obtained. Thirty minutes after a single bolus of 5,000 units of UFH, we measured an upstream ACT via a radial arterial catheter and an ACT below the arterial clamp via surgeon sampling. The quality of revascularization was assessed with preoperative and postoperative ankle-brachial and toe-brachial indexes (TBIs). RESULTS: The upstream postheparin ACT was significantly higher than the downstream postheparin ACT, with a mean difference of 24.3 sec (P < 0.0001). In 7 patients, the downstream ACT was lower than the baseline ACT. The upstream and downstream heparin concentrations were similar. There was no relationship between the downstream ACT and either ankle-brachial index improvement (28 patients, P = 0.51) or TBI improvement (27 patients, P = 0.21). CONCLUSIONS: Our study demonstrates a significant difference between the ACT above and below the arterial clamp without any clinical impact of this possibly insufficient anticoagulation. Further investigations are warranted to determine the optimal dose of UFH in vascular surgery. TRIAL REGISTRATION: Clinicaltrials.gov, NCT02477072. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Roy, Maxim AU - Roy M AD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Canada. Electronic address: maxim.roy20@gmail.com. FAU - Todorov, Alexandre AU - Todorov A AD - Washington University in St. Louis (WUSTL), St-Louis, USA. FAU - Ruel, Monique AU - Ruel M AD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Canada. FAU - Elkouri, Stephane AU - Elkouri S AD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Canada. FAU - Hardy, Jean-Francois AU - Hardy JF AD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Canada. LA - eng SI - ClinicalTrials.gov/NCT02477072 PT - Comparative Study PT - Journal Article PT - Observational Study DEP - 20180223 PL - Netherlands TA - Ann Vasc Surg JT - Annals of vascular surgery JID - 8703941 RN - 0 (Anticoagulants) RN - 9005-49-6 (Heparin) SB - IM MH - Aged MH - Aged, 80 and over MH - Ankle Brachial Index MH - Anticoagulants/*administration & dosage/adverse effects MH - Constriction MH - Female MH - Heparin/*administration & dosage/adverse effects MH - Humans MH - Male MH - Middle Aged MH - Monitoring, Intraoperative/methods MH - Peripheral Arterial Disease/blood/diagnosis/*surgery MH - Pilot Projects MH - Prospective Studies MH - Treatment Outcome MH - Vascular Surgical Procedures/adverse effects/instrumentation/*methods MH - Whole Blood Coagulation Time EDAT- 2018/02/27 06:00 MHDA- 2018/10/24 06:00 CRDT- 2018/02/27 06:00 PHST- 2017/07/03 00:00 [received] PHST- 2017/10/17 00:00 [revised] PHST- 2017/11/12 00:00 [accepted] PHST- 2018/02/27 06:00 [pubmed] PHST- 2018/10/24 06:00 [medline] PHST- 2018/02/27 06:00 [entrez] AID - S0890-5096(18)30162-6 [pii] AID - 10.1016/j.avsg.2017.11.060 [doi] PST - ppublish SO - Ann Vasc Surg. 2018 Jul;50:242-248. doi: 10.1016/j.avsg.2017.11.060. Epub 2018 Feb 23.